Skip to main content
SpringerLink
Log in

Auf dem Weg zur personalisierten Asthmamedizin

  • Medizin aktuell
  • Published:
Pädiatrie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Normansell R et al. Omalizumab for asthma in adults and children. Cochrane Database Syst Rev. 2014;(1):CD003559

  2. Bacharier LB et al. Dupilumab in children with uncontrolled moderate-to-severe asthma. N Engl J Med. 2021;385(24):2230-40

  3. Bacharier LB et al. Vortrag auf AAAAI. 2022

  4. Menzies-Gow A et al. Tezepelumab in adults and adolescents with severe, uncontrolled asthma. N Engl J Med. 2021;384(19):1800-9

Download references

Author information

Authors and Affiliations

  1. Freie Medizinjournalistin, Dresden, Germany

    Sabrina Kempe

Authors
  1. Sabrina Kempe
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kempe, S. Auf dem Weg zur personalisierten Asthmamedizin. Pädiatrie 34, 54–55 (2022). https://doi.org/10.1007/s15014-022-4765-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15014-022-4765-y

Search

Navigation